Modern-day eunuchs: Motivations for and consequences of contemporary castration

Perspectives in Biology and Medicine

Volumn 50, Issue 4, 2007, Pages 544-556

  Wassersug, Richard J ^a   Johnson, Thomas W ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Roshambo Winery   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GOSERELIN; LEUPRORELIN; TESTOSTERONE;

ADVANCED CANCER; CASTRATION; CHILD ABUSE; DEPRESSION; DISEASE ASSOCIATION; EMOTION; EUNUCHOIDISM; FUNCTIONAL ASSESSMENT; HERMAPHRODITISM; HOMOSEXUALITY; HUMAN; MALE TO FEMALE TRANSSEXUAL; MOTIVATION; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; PUNISHMENT; REVIEW; SELF ESTEEM; SEXUAL DEVIATION; SOCIAL STATUS;

EID: 35348859605     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2007.0058     Document Type: Review

References (30)

1. Aucoin, M., and R. J. Wassersug. 2006. The sexuality and social performance of androgen-deprived (castrated) men throughout history: Implications for modern day cancer patients. Soc Sci Med 63(12):3162-73.
2. Beer, T. M., et al. 2006. Testosterone loss and estradiol administration modify memory in men. J Urol 175(1):130-35.
3. Bloch, S., et al. 2007. Psychological adjustment of men with prostate cancer: A review of the literature. Biopsychosoc Med 2007, 1:2.
4. Bogaert, A. F. 2004. Asexuality: Prevalence and associated factors in a national probability sample. J Sex Res 41(3):279-87.
5. Brett, M. A., et al. 2007. Eunuchs in contemporary society: Expectations, consequences and adjustments to castration. J Sex Med 4:946-955.
6. Chapple, A., and S. Ziebland. 2002. Prostate cancer: Embodied experience and perceptions of masculinity. Sociol Health Illn 24(6):820-41.
7. Deshotels, T. H., and C. J. Forsyth. 2007. Postmodern masculinities and the eunuch. Deviant Behav 28(3):201-18.
8. Fergus, K. D., R. E. Gray, and M. I. Fitch. 2002. Sexual dysfunction and the preservation of manhood: Experiences of men with prostate cancer. J Health Psychol 7(3):303-16.
9. Gray, R. E., et al. 2005. The experiences of men receiving androgen deprivation treatment for prostate cancer: A qualitative study. Can J Urol 12(4):2755-63.
10. Higano, C. S. 2003. Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity. Urology 61(2 suppl. 1):32-38.
11. Jackson, S. 2006. Interchanges: Gender, sexuality and heterosexuality: The complexity (and limits) of heteronormativity. Feminist Theory 7(1):105-21.
12. Johnson, T. W., et al. 2007. Eunuchs in contemporary society: Characterizing men who are voluntarily castrated. J Sex Med 4:930-945.
13. Keating, N. L., A. J. O'Malley, and M. R. Smith. 2006. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24(27):4448-56.
14. Murthy, V., et al. 2007. Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer. BJU Int 99(6):1380-82.
15. Navon, L., and A. Morag. 2003. Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality and spousal ties. Qual Health Res 13(10):1378-92.
16. Navon, L., and A. Morag. 2004. Liminality as biographical disruption: Unclassifiability following hormone therapy for advanced prostate cancer. Soc Sci Med 58(11):2337-47.
17. Oliffe, J. L. 2005. Constructions of masculinity following prostatectomy-induced impotence. Soc Sci Med 60(10):2249-59.
18. Oliffe, J. L. 2006. Embodied masculinity and androgen deprivation therapy. Sociol Health Ill 28 (4):410-32.
19. Roesch, S. C., et al. 2005. Coping with prostate cancer: A meta-analytic review. J Behav Med 8(3):281-93.
20. Schover, L. R. 2001. Sexuality and cancer: For the man who has cancer and his partner. Atlanta: American Cancer Society.
21. Shahinian, V. B., et al. 2006. Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 166(4):465-71.
22. Smith, M. R., et al. 2006. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 175(1):136-39.
23. Soloway, C. T., et al. 2005. Sexual, psychological and dyadic qualities of the prostate cancer "couple." BJU Int 95(6):780-85.
24. Wassersug, R. J. 2003. Castration anxiety. OUT (Sept.):66-72.
25. Wassersug, R. J. 2007. Disfiguring treatment? No, it was healing. NY Times, March 3. http://www.nytimes.com/2007/03/27/health/27case.html.
26. Wassersug, R. J., S. A. Zelenietz, and G. F. Squire. 2004. New age eunuchs: Motivation and rationale for voluntary castration. Arch Sex Behav 33(5):433-42.
27. Wassersug, R. J., et al. 2007. Experiences of transwomen with hormone therapy. Sexualities 10(1):101-22.
28. Zita, J. N. 1998. Body talk: Philosophical reflections on sex and gender. New York: Columbia Univ. Press.
29. Zitzmann, M., and E. Nieschlag. 2000. Hormone substitution in male hypogonadism. Mol Cell Endocrinol 161(1-2):73-88.
30. Zitzmann, M., and E. Nieschlag. 2001. Testosterone levels in healthy men and the relation to behavioural and physical characteristics: Facts and constructs. Eur J Endocrinol 144(3):183-97.